Literature DB >> 3542315

Monoclonal antibody against bacterial lipopolysaccharide cross-reacts with DNA-histone.

R Sumazaki, T Fujita, T Kabashima, F Nishikaku, A Koyama, M Shibasaki, H Takita.   

Abstract

Monoclonal antibodies to bacterial lipopolysaccharide (LPS) were prepared by fusing spleen cells from BALB/c mice immunized with Salmonella Minnesota Re 595 LPS to the mouse myeloma cell line P3U1. One of them, designated RS01, revealed a strong positive antinuclear activity and reacted with DNA-histone. RS01 also bound specifically to Salmonella Minnesota Re 595 LPS and eliminated the biological activity of LPS. The Salmonella completely inhibited the ANA activity of RS01 and DNA-histone blocked the reactivity of RS01 with LPS. Thus, it is clear that an anti-LPS monoclonal antibody, RS01 cross-reacts with DNA-histone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542315      PMCID: PMC1542644     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

Review 1.  Thymus-independent B-cell induction and paralysis.

Authors:  A Coutinho; G Möller
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  A two-stage indirect L.E. cell test.

Authors:  P J LACHMANN
Journal:  Immunology       Date:  1961-04       Impact factor: 7.397

4.  Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice; II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators.

Authors:  S Izui; T Kobayakawa; M J Zryd; J Louis; P H Lambert
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

5.  An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

6.  Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins.

Authors:  S Iwanaga; T Morita; T Harada; S Nakamura; M Niwa; K Takada; T Kimura; S Sakakibara
Journal:  Haemostasis       Date:  1978

7.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

9.  Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.

Authors:  J I Ito; A C Wunderlich; J Lyons; C E Davis; D G Guiney; A I Braude
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

10.  Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides.

Authors:  G J Fournié; P H Lambert; P A Meischer
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  2 in total

1.  Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

Authors:  Maria Gounari; Stavroula Ntoufa; Benedetta Apollonio; Nikos Papakonstantinou; Maurilio Ponzoni; Charles C Chu; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Kostas Stamatopoulos; Paolo Ghia
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

2.  Structural Basis for Antibody Recognition of Lipid A: INSIGHTS TO POLYSPECIFICITY TOWARD SINGLE-STRANDED DNA.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.